WMS Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

WMS Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,908	Closed	-$310K	–	293
2022 Q3	$310K	Sell	3,908 -2,106	-35%	-$178K	0.04%	186
2022 Q2	$447K	Buy	6,014 +2,885	+92%	+$217K	0.07%	147
2022 Q1	$281K	Buy	3,129 +1,125	+56%	+$104K	0.04%	193
2021 Q4	$224K	Hold	2,004	–	–	0.05%	195
2021 Q3	$252K	Hold	2,004	–	–	0.04%	232
2021 Q2	$271K	Buy	2,004 +125	+7%	+$16.4K	0.04%	216
2021 Q1	$255K	Hold	1,879	–	–	0.06%	191
2020 Q4	$265K	Hold	1,879	–	–	0.05%	203
2020 Q3	$209K	Hold	1,879	–	–	0.04%	216
2020 Q2	$210K	Buy	+1,879	New	+$185K	0.04%	200
2020 Q1	–	Sell	-6,435	Closed	-$612K	–	229
2019 Q4	$612K	Buy	+6,435	New	+$557K	0.14%	94

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

WMS Partners's XBI Position: Q4 2022 in Review

WMS Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2022, closing a stake of 3,908 shares — an estimated $310K sold.

WMS Partners first reported a position in XBI in Q4 2019 and held it in 11 quarters. The position peaked at $612K in Q4 2019. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

WMS Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2022 after selling out during the quarter.
WMS Partners sold 3,908 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $310K.
WMS Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 11 quarters.
WMS Partners's State Street SPDR S&P Biotech ETF position peaked at $612K in Q4 2019.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on WMS Partners's 13F filing for Q4 2022, filed 7 Feb 2023.